Gastric Microbial Community Profiling Reveals a Dysbiotic Cancer-associated Microbiota
Overview
Authors
Affiliations
Objective: Gastric carcinoma development is triggered by . Chronic infection leads to reduced acid secretion, which may allow the growth of a different gastric bacterial community. This change in the microbiome may increase aggression to the gastric mucosa and contribute to malignancy. Our aim was to evaluate the composition of the gastric microbiota in chronic gastritis and in gastric carcinoma.
Design: The gastric microbiota was retrospectively investigated in 54 patients with gastric carcinoma and 81 patients with chronic gastritis by 16S rRNA gene profiling, using next-generation sequencing. Differences in microbial composition of the two patient groups were assessed using linear discriminant analysis effect size. Associations between the most relevant taxa and clinical diagnosis were validated by real-time quantitative PCR. Predictive functional profiling of microbial communities was obtained with PICRUSt.
Results: The gastric carcinoma microbiota was characterised by reduced microbial diversity, by decreased abundance of and by the enrichment of other bacterial genera, mostly represented by intestinal commensals. The combination of these taxa into a microbial dysbiosis index revealed that dysbiosis has excellent capacity to discriminate between gastritis and gastric carcinoma. Analysis of the functional features of the microbiota was compatible with the presence of a nitrosating microbial community in carcinoma. The major observations were confirmed in validation cohorts from different geographic origins.
Conclusions: Detailed analysis of the gastric microbiota revealed for the first time that patients with gastric carcinoma exhibit a dysbiotic microbial community with genotoxic potential, which is distinct from that of patients with chronic gastritis.
Gut microbiota therapy in gastrointestinal diseases.
Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman S Front Cell Dev Biol. 2025; 13:1514636.
PMID: 40078367 PMC: 11897527. DOI: 10.3389/fcell.2025.1514636.
Emerging roles of intratumoral microbiota: a key to novel cancer therapies.
Fang P, Yang J, Zhang H, Shuai D, Li M, Chen L Front Oncol. 2025; 15:1506577.
PMID: 40071093 PMC: 11893407. DOI: 10.3389/fonc.2025.1506577.
Environmental factors in gastric carcinogenesis and preventive intervention strategies.
Tan Y, Matsuzaki J, Saito Y, Suzuki H Genes Environ. 2025; 47(1):5.
PMID: 40045434 PMC: 11881338. DOI: 10.1186/s41021-025-00328-w.
Common occurrence of atrophic gastritis in an ageing non-hospitalised population: an autopsy study.
Karhunen P, Tuomisto S, Goebeler S, Martiskainen M, Kok E Age Ageing. 2025; 54(3).
PMID: 40037561 PMC: 11879357. DOI: 10.1093/ageing/afaf047.
Wizenty J, Sigal M Nat Rev Gastroenterol Hepatol. 2025; .
PMID: 40011753 DOI: 10.1038/s41575-025-01042-2.